Business
CSL to manufacture 81m COVID-19 vaccine doses by mid-2021 – The Australian Financial Review
CSL has secured agreements with AstraZeneca to produce 30 million doses of its vaccine candidate locally if the drug is successful.
The two deals are expected to cost the government more than $1.7 billion, if the vaccines become available.
At this stage the AstraZeneca vaccine is more advanced and is considered the leading candidate globally, with phase-three clinical trials already starting. The first doses are scheduled for release early next year. The UQ vaccine is expected to be ready a short time later in mid-2021.
CSL chief scientific officer Dr Andrew Nash was optimistic about the potential for a vaccine in early 2…
-
Noosa News23 hours agoGold Coast teenager charged after allegedly stabbing female Uber driver outside Westfield Coomera
-
Noosa News21 hours agoBrisbane radio station refers to Senator Fatima Payman as ‘slag’
-
General21 hours agoNewcastle man pleads guilty to possessing 34,000 child abuse images and 13 bestiality videos
-
Noosa News21 hours agoPlan for new apartment tower sparks backlash in West End